All stock lists
Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
Healthcare · Biotechnology
23.73+0.18 (+0.79%)
Insider Score
––Not scored
NGNE Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
NGNE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | -100.00 % | — |
| Cost of Revenue | 0.00 | 854.00 K | 787.00 K | 17.24 M | 19.37 M | 17.76 M |
| Gross Profit | 0.00 | -854.00 K | -787.00 K | -17.24 M | -19.37 M | -17.76 M |
| SG&A Expense | 11.20 M | 8.20 M | 6.10 M | 6.56 M | 6.71 M | 8.16 M |
| R&D Expense | 25.47 M | 25.15 M | 20.64 M | 17.24 M | 19.37 M | 17.76 M |
| Operating Expenses | 36.67 M | 32.49 M | 26.74 M | 6.56 M | 6.71 M | 8.16 M |
| Operating Income | -36.67 M | -33.35 M | -27.53 M | -23.80 M | -26.08 M | -25.92 M |
| Pretax Income | -34.49 M | -30.93 M | -24.73 M | -20.95 M | -22.02 M | -22.65 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -34.49 M | -30.93 M | -24.73 M | -20.95 M | -22.02 M | -22.65 M |
| EPS (Basic) | -1.53 | -1.39 | -1.60 | -0.99 | -1.05 | -1.08 |
| EPS (Diluted) | -1.53 | -1.39 | -1.60 | -0.99 | -1.05 | -1.08 |
| Shares Outstanding | 22.55 M | 22.31 M | 15.49 M | 21.17 M | 21.06 M | 21.00 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.